YIH
MIRM icon

Y-Intercept (HK)’s Mirum Pharmaceuticals MIRM Stock Holding History

Y-Intercept (HK)’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,368
Closed -$1.13M – 1867
2025
Q4 		$1.13M Buy
14,368
+3,343
+30% +$240K 0.03% 924
2025
Q3 		$808K Buy
+11,025
New +$701K 0.02% 1074
2024
Q4 		– Sell
-5,516
Closed -$215K – 1478
2024
Q3 		$215K Buy
+5,516
New +$220K 0.01% 1134

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Y-Intercept (HK)'s MIRM Position: Q1 2026 in Review

Y-Intercept (HK) sold out of Mirum Pharmaceuticals (MIRM) in Q1 2026, closing a stake of 14,368 shares — an estimated $1.13M sold.

Y-Intercept (HK) first reported a position in MIRM in Q3 2024 and held it in 3 quarters. The position peaked at $1.13M in Q4 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Y-Intercept (HK) reported no remaining Mirum Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 14,368 Mirum Pharmaceuticals shares in Q1 2026, an estimated $1.13M.
  • Y-Intercept (HK) first reported a position in Mirum Pharmaceuticals in Q3 2024 and held it in 3 quarters.
  • Y-Intercept (HK)'s Mirum Pharmaceuticals position peaked at $1.13M in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.